What's New

Fedratinib (Inrebic®)

Fedratinib (Inrebic®) is a type of targeted therapy called a kinase inhibitor, used in the treatment of Myelofibrosis.

Entrectinib (Rozlytrek™)

Entrectinib (Rozlytrek™) is a kinase inhibitor used in the treatment of non small cell lung cancer and other solid tumors with certain neurotrophic receptor kinase (NTRK) genes.


OncoLink's Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

Managing Student Loans and Cancer
by Christina Bach, MSW, LCSW, OSW-C
Sep 12, 2019

Scholarships for Students Impacted by Cancer
by Christina Bach, MSW, LCSW, OSW-C
Sep 10, 2019

Proton Therapy for Breast Cancer
by Christina Bach, MSW, LCSW, OSW-C
Sep 9, 2019

View all Blogs

Childhood Cancer Awareness

Each year in the United States almost 16,000 people under the age of 21 are diagnosed with cancer. September is Childhood Cancer Awareness Month and these cancers are highlighted through education, raising awareness of survivorship concerns, and raising money. Visit OncoLink Jr. for lots of pediatric cancer resources!

Need Cancer Patient Education Tools?

Our award winning cancer education content is now available for licensing and syndication.

I Wish U Knew!

I Wish U Knew is a video series featuring oncology professionals and survivors discussing what they wish patients and the public knew about cancer.